Gene therapy biotech Genenta raises €13.2m in funding round
Milan-based clinical stage biotech Genenta Science has announced it has raised €13.2m at the closing...
Read More...
Focus:
Italy
-
![Sofinnova sells Breath Therapeutics to Zambon]()
Sofinnova sells Breath Therapeutics to Zambon in $550m deal
Venture capital firm Sofinnova Partners has dispossessed its portfolio company Breath Therapeutics to Italian pharmaceutical...
Read More...
-
![Recordati acquires rights to Signifor and osilodrostat from Novartis]()
Recordati acquires rights to Signifor and osilodrostat from Novartis
Recordati has agreed to acquire the global rights to two of Novartis’ medicines, Signifor and...
Read More...
-
![Italy pharma industry]()
Inside Italy’s pharmaceutical industry
Last year, three of the five top US exports to Italy were health related, and...
Read More...
-
Deals this week: Olon SpA, MannKind, Shire
Olon SpA has agreed to purchase an active pharmaceutical ingredient (API) manufacturing plant located in...
Read More...
-
![]()
Italy’s Senate ends parental obligation to vaccinate school children
The upper house of Italy’s parliament has passed an amendment supported by the government to...
Read More...
-
M&As this week: Catalent, CVC, Bain Capital Private Equity
Catalent has agreed to acquire Juniper Pharmaceuticals, along with its Juniper Pharma Services division based...
Read More...
-
CVC to buy majority stake in drugmaker Recordati for €3bn
Private equity firm CVC Capital Partners has signed an agreement to acquire a 51.8% stake...
Read More...
-
M&As this week: AstraZeneca, Mega Labs, Toho Holdings
AstraZeneca has agreed to purchase an additional 5.7% stake in Circassia Pharmaceuticals in a cash...
Read More...
-
Deals this week: China Meheco, Recordati, Novartis
China Meheco intends to form a Chinese pharmaceutical joint venture (JV) through its subsidiary with a...
Read More...